In some cases, diagnostic testing such as upper gastrointestinal imaging or gastric emptying studies may be appropriate to assess gastric function
However, Canadian researchers can access Retatrutide through research peptide suppliers who ship domestically
Your GP should assess metabolic risk factors, perform non-invasive fibrosis testing (FIB-4 or NAFLD Fibrosis Score), and refer you to a hepatologist if advanced fibrosis is suspected or liver function tests remain persistently abnormal
Front-loading protein is critical when appetite is suppressed
In Canada, Zepbound is approved as a long-term treatment for adults with obesity (BMI 30), or those who are overweight (BMI 27) and living with at least one weight-related health condition (including hypertension, dyslipidemia, type 2 diabetes, obstructive sleep apnea, or cardiovascular disease)
No two individuals are alike, and a one-size-fits-all approach is unlikely to yield sustainable results